Supernus Pharmaceuticals Inc (SUPN)

Gross profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Gross profit	US$ in thousands	-1	205,614	177,659	243,526	216,170
Revenue	US$ in thousands	607,521	673,056	560,079	500,962	392,755
Gross profit margin		-0.00%	30.55%	31.72%	48.61%	55.04%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $-1K ÷ $607,521K
= -0.00%

The gross profit margin of Supernus Pharmaceuticals Inc has exhibited a declining trend over the past five years. Starting at a high of 95.76% in 2019, the margin has gradually decreased to 86.21% in 2023. While a high gross profit margin typically indicates efficient production and pricing strategies, the decreasing trend may suggest potential challenges in controlling costs or maintaining pricing power. Further investigation into the company's cost structure and pricing strategies is warranted to fully understand the factors contributing to this declining trend.